Studies of Neuregulin/ERBB Signaling in Human Heart

NCT02820233 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-04-03

No results posted yet for this study

Summary

This study examines the role of the epidermal growth factor (EGF) receptor family and the EGF family of ligands in the regulation of non-myocytes isolated from the human heart.

Conditions

Sponsors & Collaborators

  • MaineHealth

    collaborator OTHER
  • Douglas B. Sawyer

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2028-09-30
Completion
2029-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02820233 on ClinicalTrials.gov